Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells.

Knoepfler PS.

Regen Med. 2012 Sep;7(5):713-20. doi: 10.2217/rme.12.51. Epub 2012 Jul 26. Review.

PMID:
22830621
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects.

Hug K, Hermerén G.

Stem Cell Rev. 2011 Nov;7(4):761-74. doi: 10.1007/s12015-011-9257-3. Review.

PMID:
21461713
[PubMed - indexed for MEDLINE]
3.

Developing defined culture systems for human pluripotent stem cells.

Valamehr B, Tsutsui H, Ho CM, Wu H.

Regen Med. 2011 Sep;6(5):623-34. doi: 10.2217/rme.11.54. Review.

PMID:
21916597
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.

Kingham E, Oreffo RO.

ACS Nano. 2013 Mar 26;7(3):1867-81. doi: 10.1021/nn3037094. Epub 2013 Feb 15. Review.

PMID:
23414366
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Current applications of human pluripotent stem cells: possibilities and challenges.

Ho PJ, Yen ML, Yet SF, Yen BL.

Cell Transplant. 2012;21(5):801-14. doi: 10.3727/096368911X627507. Epub 2012 Mar 22. Review.

PMID:
22449556
[PubMed - indexed for MEDLINE]
6.

How far are induced pluripotent stem cells from the clinic?

Li M, Chen M, Han W, Fu X.

Ageing Res Rev. 2010 Jul;9(3):257-64. doi: 10.1016/j.arr.2010.03.001. Epub 2010 Apr 1. Review.

PMID:
20362696
[PubMed - indexed for MEDLINE]
7.

Induced pluripotent stem cells, new tools for drug discovery and new hope for stem cell therapies.

Shi Y.

Curr Mol Pharmacol. 2009 Jan;2(1):15-8. Review.

PMID:
20021441
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Hong SG, Dunbar CE, Winkler T.

Mol Ther. 2013 Feb;21(2):272-81. doi: 10.1038/mt.2012.255. Epub 2012 Dec 4. Review.

PMID:
23207694
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Induced pluripotent stem cells for cardiac repair.

Zwi-Dantsis L, Gepstein L.

Cell Mol Life Sci. 2012 Oct;69(19):3285-99. doi: 10.1007/s00018-012-1078-2. Epub 2012 Jul 20. Review.

PMID:
22960788
[PubMed - indexed for MEDLINE]
10.

Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine.

Nostro MC, Keller G.

Semin Cell Dev Biol. 2012 Aug;23(6):701-10. doi: 10.1016/j.semcdb.2012.06.010. Epub 2012 Jun 26. Review.

PMID:
22750147
[PubMed - indexed for MEDLINE]
11.

Human induced pluripotent stem cells from basic research to potential clinical applications in cancer.

Fernandez Tde S, de Souza Fernandez C, Mencalha AL.

Biomed Res Int. 2013;2013:430290. doi: 10.1155/2013/430290. Epub 2013 Oct 28. Review.

PMID:
24288679
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Inducing iPSCs to escape the dish.

Barrilleaux B, Knoepfler PS.

Cell Stem Cell. 2011 Aug 5;9(2):103-11. doi: 10.1016/j.stem.2011.07.006. Review.

PMID:
21816362
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Cardiomyocyte generation using stem cells and directly reprogrammed cells.

Ieda M, Fukuda K.

Front Biosci (Schol Ed). 2012 Jun 1;4:1413-23. Review.

PMID:
22652883
[PubMed - indexed for MEDLINE]
14.

Human pluripotent stem cells for disease modelling and drug screening.

Maury Y, Gauthier M, Peschanski M, Martinat C.

Bioessays. 2012 Jan;34(1):61-71. doi: 10.1002/bies.201100071. Epub 2011 Oct 28. Review.

PMID:
22038777
[PubMed - indexed for MEDLINE]
15.

Pluripotent stem cells and gene therapy.

Simara P, Motl JA, Kaufman DS.

Transl Res. 2013 Apr;161(4):284-92. doi: 10.1016/j.trsl.2013.01.001. Epub 2013 Jan 23. Review.

PMID:
23353080
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Human induced pluripotent stem cells: a review of the US patent landscape.

Georgieva BP, Love JM.

Regen Med. 2010 Jul;5(4):581-91. doi: 10.2217/rme.10.43. Review.

PMID:
20632861
[PubMed - indexed for MEDLINE]
17.

Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.

Yim R.

Transfusion. 2005 Oct;45(4 Suppl):144S-58S. Review.

PMID:
16181400
[PubMed - indexed for MEDLINE]
18.

Reprogrammed cells for disease modeling and regenerative medicine.

Cherry AB, Daley GQ.

Annu Rev Med. 2013;64:277-90. doi: 10.1146/annurev-med-050311-163324. Review.

PMID:
23327523
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Alternative sources of adult stem cells: a possible solution to the embryonic stem cell debate.

Moore KE, Mills JF, Thornton MM.

Gend Med. 2006 Sep;3(3):161-8. Review.

PMID:
17081949
[PubMed - indexed for MEDLINE]
20.

Current progress and potential practical application for human pluripotent stem cells.

Philonenko ES, Shutova MV, Chestkov IV, Lagarkova MA, Kiselev SL.

Int Rev Cell Mol Biol. 2011;292:153-96. doi: 10.1016/B978-0-12-386033-0.00004-9. Review.

PMID:
22078961
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk